Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: recommendations for Standardized Imaging and Reporting from the Society of Abdominal Radiology IPMN disease focused panel
暂无分享,去创建一个
Stella K Kang | Justin M Ream | Namita S. Gandhi | D. Sahani | A. Zaheer | E. Hecht | I. Francis | A. Megibow | P. Bhosale | D. Morgan | V. Yaghmai | Justin Ream | Lyndon Luk | Chenchan Huang | Ravi K Kaza | R. Kaza | Stella K. Kang | David Hough | G. Khatri | L. Luk | David M. Hough | N. Gandhi | D. Hough | J. Ream
[1] J. Lee,et al. Clinical Feasibility of Abbreviated Magnetic Resonance With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm , 2020, Investigative radiology.
[2] B. Hamm,et al. Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma. , 2019, European journal of radiology.
[3] M. Fukayama,et al. Long-term Risk of Malignancy in Branch Duct Intraductal Papillary Mucinous Neoplasms. , 2019, Gastroenterology.
[4] Ivan Pedrosa,et al. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. , 2019, Radiology.
[5] Eun Sun Lee,et al. Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions: 2017 Consensus Recommendations of the Korean Society of Abdominal Radiology , 2019, Korean journal of radiology.
[6] Shivani Gupta,et al. Higher Growth Rate of Branch Duct Intraductal Papillary Mucinous Neoplasms Associates With Worrisome Features , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[7] Mihir S. Wagh,et al. Feasibility and safety of microforceps biopsy in the diagnosis of pancreatic cysts. , 2018, Gastrointestinal endoscopy.
[8] Mihir S. Wagh,et al. Technical feasibility, diagnostic yield, and safety of microforceps biopsies during EUS evaluation of pancreatic cystic lesions (with video). , 2018, Gastrointestinal endoscopy.
[9] B. Siewert,et al. Utility of transabdominal ultrasound for surveillance of known pancreatic cystic lesions: prospective evaluation with MRI as reference standard , 2018, Abdominal Radiology.
[10] B. Enestvedt,et al. ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts , 2018, The American Journal of Gastroenterology.
[11] E. Hecht,et al. Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance Cohort , 2018, Pancreas.
[12] Marco Marc Lianne Marco J Djuna L Thomas M Jeanin E Mark Del Chiaro Besselink Scholten Bruno Cahen G. European evidence-based guidelines on pancreatic cystic neoplasms , 2018, Gut.
[13] Jin‐Young Jang,et al. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size. , 2018, Gastroenterology.
[14] J. Han,et al. Transabdominal Ultrasound Detection of Pancreatic Cysts Incidentally Detected at CT, MRI, or Endoscopic Ultrasound. , 2018, AJR. American journal of roentgenology.
[15] C. F. Fernandez-del Castillo,et al. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Strategic Considerations , 2017, Visceral Medicine.
[16] M. Pittman,et al. Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas. , 2017, Archives of pathology & laboratory medicine.
[17] K. Lillemoe,et al. Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[18] K. Lillemoe,et al. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center. , 2017, Gastroenterology.
[19] Y. Oda,et al. SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas. , 2017, Human pathology.
[20] D. Sahani,et al. Management of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings Committee. , 2017, Journal of the American College of Radiology : JACR.
[21] E. Hecht,et al. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms. , 2017, AJR. American journal of roentgenology.
[22] S. Silverman,et al. Society of Abdominal Radiology Disease-Focused Panel Program: rationale for its genesis and status report , 2017, Abdominal Radiology.
[23] H. Yamaue,et al. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas , 2017, JAMA surgery.
[24] M. Falconi,et al. Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management , 2017, The American Journal of Gastroenterology.
[25] J. Han,et al. Diagnostic performance and imaging features for predicting the malignant potential of intraductal papillary mucinous neoplasm of the pancreas: a comparison of EUS, contrast-enhanced CT and MRI , 2017, Abdominal Radiology.
[26] Young Kon Kim,et al. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with “high-risk stigmata” of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness , 2017, Acta radiologica.
[27] N. Adsay,et al. The Evolving Role of Pathology in New Developments, Classification, Terminology, and Diagnosis of Pancreatobiliary Neoplasms. , 2017, Archives of pathology & laboratory medicine.
[28] T. Itoi,et al. Effectiveness of contrast-enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions , 2016, Endoscopic ultrasound.
[29] Jin-Ming Wu,et al. Utility of the 2006 Sendai and 2012 Fukuoka guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas , 2016, Medicine.
[30] Jae Ho Byun,et al. Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance Imaging: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2016, Annals of surgery.
[31] I. Pedrosa,et al. Delayed Growth in Incidental Pancreatic Cysts: Are the Current American College of Radiology Recommendations for Follow-up Appropriate? , 2016, Radiology.
[32] Maryellen R M Sun,et al. Measurement of pancreatic cystic lesions on magnetic resonance imaging: efficacy of standards in reducing inter-observer variability , 2016, Abdominal Radiology.
[33] A. Krasinskas,et al. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas , 2015, The American journal of surgical pathology.
[34] C. Thng,et al. Evaluation of the Fukuoka Consensus Guidelines for intraductal papillary mucinous neoplasms of the pancreas: Results from a systematic review of 1,382 surgically resected patients. , 2015, Surgery.
[35] Xiaoping Zou,et al. The diagnostic value of EUS in pancreatic cystic neoplasms compared with CT and MRI , 2015, Endoscopic ultrasound.
[36] Wei Wu,et al. Application of Contrast-Enhanced Ultrasound in Cystic Pancreatic Lesions Using a Simplified Classification Diagnostic Criterion , 2015, BioMed research international.
[37] T. Savides,et al. Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy , 2015, Digestive Diseases and Sciences.
[38] P. Moayyedi,et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. , 2015, Gastroenterology.
[39] P. Moayyedi,et al. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. , 2015, Gastroenterology.
[40] C. Lightdale,et al. The role of molecular analysis in the diagnosis and surveillance of pancreatic cystic neoplasms. , 2015, JOP : Journal of the pancreas.
[41] Eun Sun Lee,et al. Intraductal papillary mucinous neoplasms of the pancreas: evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. , 2015, Radiology.
[42] C. Lightdale,et al. Demographic Features and Natural History of Intermediate-Risk Multifocal Versus Unifocal Intraductal Papillary Mucinous Neoplasms , 2014, Pancreas.
[43] T. Ohtsuka,et al. “High-Risk Stigmata” of the 2012 International Consensus Guidelines Correlate With the Malignant Grade of Branch Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2014, Pancreas.
[44] E. Zabor,et al. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. , 2014, AJR. American journal of roentgenology.
[45] T. Kang,et al. Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. , 2014, AJR. American journal of roentgenology.
[46] M. Al-Haddad,et al. International Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative. , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[47] F. Colina-Ruizdelgado,et al. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas. , 2014, World journal of gastrointestinal oncology.
[48] Namita S. Gandhi,et al. Does secretin stimulation add to magnetic resonance cholangiopancreatography in characterising pancreatic cystic lesions as side-branch intraductal papillary mucinous neoplasm? , 2014, European Radiology.
[49] Jaron J. R. Chong,et al. Incidental pancreatic cysts: natural history and diagnostic accuracy of a limited serial pancreatic cyst MRI protocol , 2014, European Radiology.
[50] S. Park,et al. Imaging Features to Distinguish Malignant and Benign Branch-Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Meta-analysis , 2014, Annals of surgery.
[51] B. Siewert,et al. Split-bolus spectral multidetector CT of the pancreas: assessment of radiation dose and tumor conspicuity. , 2013, Radiology.
[52] T. Gardner,et al. Pancreatic Cyst Prevalence and the Risk of Mucin-Producing Adenocarcinoma in US Adults , 2013, The American Journal of Gastroenterology.
[53] H. Friess,et al. European experts consensus statement on cystic tumours of the pancreas. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[54] Jeong Min Lee,et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas , 2013, Journal of magnetic resonance imaging : JMRI.
[55] Bechien U. Wu,et al. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[56] C. F. Fernandez-del Castillo,et al. Pancreatic cystic neoplasms: management and unanswered questions. , 2013, Gastroenterology.
[57] Vikesh K. Singh,et al. Should We Do EUS/FNA on Patients With Pancreatic Cysts? The Incremental Diagnostic Yield of EUS Over CT/MRI for Prediction of Cystic Neoplasms , 2013, Pancreas.
[58] D. Sahani,et al. Diagnosis and management of cystic pancreatic lesions. , 2013, AJR. American journal of roentgenology.
[59] Jun Kato,et al. Usefulness of Contrast‐Enhanced Endoscopic Sonography for Discriminating Mural Nodules From Mucous Clots in Intraductal Papillary Mucinous Neoplasms , 2013, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[60] J. H. Kim,et al. Diagnostic performance of MRI and EUS in the differentiation of benign from malignant pancreatic cyst and cyst communication with the main duct. , 2012, European journal of radiology.
[61] J. M. Lee,et al. Dual-source, dual-energy multidetector CT for the evaluation of pancreatic tumours. , 2012, The British journal of radiology.
[62] T. Ohtsuka,et al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. , 2012, American journal of surgery.
[63] C. Menias,et al. MR imaging techniques for pancreas. , 2012, Radiologic clinics of North America.
[64] Jin‐Young Jang,et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[65] A. Sauvanet,et al. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[66] Zhe Zhang,et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. , 2012, Gastroenterology.
[67] L. Buscail,et al. Long-Term Clinical and Imaging Follow-Up of Nonoperated Branch Duct Form of Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2012, Pancreas.
[68] I. Endo,et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[69] P. Fockens,et al. Disappointing Interobserver Agreement Among Radiologists for a Classifying Diagnosis of Pancreatic Cysts Using Magnetic Resonance Imaging , 2012, Pancreas.
[70] S. Choi,et al. Determination of Malignant and Invasive Predictors in Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Suggested Scoring Formula , 2011, Journal of Korean medical science.
[71] T. Furukawa,et al. Pancreatic Ductal Adenocarcinoma Derived From IPMN and Pancreatic Ductal Adenocarcinoma Concomitant With IPMN , 2011, Pancreas.
[72] Myeong-Jin Kim,et al. Relative accuracy of CT and MRI in the differentiation of benign from malignant pancreatic cystic lesions. , 2011, Clinical radiology.
[73] C. Zuiani,et al. Incidental pancreatic cysts on 3D turbo spin echo magnetic resonance cholangiopancreatography: prevalence and relation with clinical and imaging features , 2011, Abdominal Imaging.
[74] Myeong-Jin Kim,et al. Comparison of MRI and endoscopic ultrasound in the characterization of pancreatic cystic lesions. , 2010, AJR. American journal of roentgenology.
[75] Joshua A. Waters,et al. Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[76] T. Okumura,et al. Incidence of Synchronous and Metachronous Pancreatic Carcinoma in 168 Patients with Branch Duct Intraductal Papillary Mucinous Neoplasm , 2010, Pancreatology.
[77] V. Yaghmai,et al. Morphological analysis of pancreatic cystic masses. , 2010, Academic radiology.
[78] B. Gayet,et al. Pancreatic mucinous cystadenoma communicating with the main pancreatic duct on MRI. , 2009, The British journal of radiology.
[79] D. Sahani,et al. Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts. , 2009, AJR. American journal of roentgenology.
[80] Sukru Mehmet Erturk,et al. Pancreatic intraductal papillary mucinous neoplasms: role of CT in predicting pathologic subtypes. , 2008, AJR. American journal of roentgenology.
[81] D. Noll,et al. Apparent wall thickening of cystic renal lesions on MRI , 2008, Journal of magnetic resonance imaging : JMRI.
[82] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[83] Joshua A. Waters,et al. Intraductal Papillary Mucinous Neoplasms: Predictors of Malignant and Invasive Pathology , 2007, Annals of surgery.
[84] C. McCulloch,et al. Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. , 2007, AJR. American journal of roentgenology.
[85] Jae Young Lee,et al. Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: Comparison of multirow‐detector CT and MR imaging using ROC analysis , 2007, Journal of magnetic resonance imaging : JMRI.
[86] M. Mino‐Kenudson,et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. , 2007, Gastroenterology.
[87] S. Choi,et al. Intraductal papillary mucinous tumour of the pancreas: differentiation of malignancy and benignancy by CT. , 2006, Clinical radiology.
[88] Andrew J. Taylor,et al. Multimodality imaging of pancreatic and biliary congenital anomalies. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.
[89] S. Chari,et al. International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas , 2006, Pancreatology.
[90] D. Sahani,et al. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP. , 2006, Radiology.
[91] C. Bassi,et al. Main-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: Clinical Predictors of Malignancy and Long-term Survival Following Resection , 2004, Annals of surgery.
[92] Y. Atomi,et al. Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. , 1998, Annals of surgery.
[93] T. Muto,et al. Analysis of small cystic lesions of the pancreas , 1995, International journal of pancreatology : official journal of the International Association of Pancreatology.
[94] Diseases of the Nervous System , 1906, The Hospital.
[95] Jin‐Young Jang,et al. Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. , 2016, Annals of surgery.
[96] J. Laukkarinen,et al. Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol , 2016, European Radiology.
[97] Qiang Sun,et al. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis. , 2015, Biomedical reports.
[98] L. Haramati,et al. Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality? , 2015, Radiology.
[99] Elliot K Fishman,et al. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. , 2014, Radiology.
[100] R. Perez-Johnston,et al. Frequency and significance of calcification in IPMN. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[101] Jin‐Young Jang,et al. Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[102] M. Macari,et al. Is gadolinium necessary for MRI follow-up evaluation of cystic lesions in the pancreas? Preliminary results. , 2009, AJR. American journal of roentgenology.
[103] Joshua A. Waters,et al. CT vs MRCP: Optimal Classification of IPMN Type and Extent , 2007, Journal of Gastrointestinal Surgery.
[104] D. Hough,et al. Incidentally Discovered Pancreatic Cysts The Natural History of the Incidentally Discovered Small Simple Pancreatic Cyst : Long-Term Follow-Up and Clinical Implications , 2004 .